Lead sponsor
Massachusetts General Hospital
5 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
5
Trials led
0
Ongoing
48
Total enrollment
4
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1/2
1
Phase 2
1
Phase 4
1
Not applicable
2
Trials by status
Completed
3
Withdrawn
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.Alzheimer's diseasePh 4Completed11
A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.Alzheimer's diseasePh 2Withdrawnnot disclosed
Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With RamelteonDementia with Lewy bodiesN/AWithdrawnnot disclosed